SCHEMBL26455661

SCHEMBL26455661

c1ccc(-c2cc(-c3ccc4c(c3)[Si]3(c5ccccc5Oc5cc(-n6c7ccccc7c7ccccc76)ccc53)c3ccccc3O4)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.34
▸ MEN1 O00255 6/20 0.34
▸ KMT2A Q03164 6/20 0.34
▸ ALDH1A1 P00352 6/20 0.34
▸ HPGD P15428 6/20 0.34
▸ NTSR1 P30989 1/20 0.34
▸ KDM4E B2RXH2 5/20 0.34
▸ LMNA P02545 2/20 0.34
▸ GLA P06280 1/20 0.34
▸ EDNRB P24530 1/20 0.33
▸ EDNRA P25101 1/20 0.33
▸ ADORA2A P29274 3/20 0.33
▸ ADORA1 P30542 3/20 0.33
▸ MAOA P21397 2/20 0.32
▸ MAOB P27338 2/20 0.32
▸ ADORA3 P0DMS8 1/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ MAPK1 P28482 2/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26455697 0.96 MAPT (0.36) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL26455585 0.93 EDNRB (0.35) KDM4ELMNAEDNRBEDNRAL3MBTL1
SCHEMBL26455674 0.92 MEN1 (0.36) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL26455617 0.89 EDNRA (0.36) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL26455654 0.85 ADORA1 (0.35) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL26455595 0.85 KDM4E (0.35) KDM4ELMNAEDNRBEDNRAL3MBTL1
SCHEMBL26455652 0.84 MEN1 (0.47) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL26455685 0.83 ADORA1 (0.35) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL26455566 0.82 CYP1A2 (0.32) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL20934392 0.82 MAPT (0.41) MAPTMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230140120-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-04 — — US disclosed
US-20230140120-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230140120-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, CYBA, INF2 MAPT 3870/4885MEN1 140/4885KMT2A 1394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback